PAPER Chang J, Rimando A, Pallas M, Camins A, Porquet D, Reeves J, Shukitt-Hale B, Smith MA, Joseph JA, Casadesus G
SEARCH RESULTS
331256 RESULTS
PAPER Lee YJ, Choi DY, Choi IS, Han JY, Jeong HS, Han SB, Oh KW, Hong JT
Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells.
J Neuroinflammation. 2011;8:132. PubMed: 21982455PAPER Costa AP, Tramontina AC, Biasibetti R, Batassini C, Lopes MW, Wartchow KM, Bernardi C, Tortorelli LS, Leal RB, Gonçalves CA
Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia.
Behav Brain Res. 2012 Jan 15;226(2):420-7. PubMed: 21982813PAPER Marwarha G, Dasari B, Ghribi O
Endoplasmic reticulum stress-induced CHOP activation mediates the down-regulation of leptin in human neuroblastoma SH-SY5Y cells treated with the oxysterol 27-hydroxycholesterol.
Cell Signal. 2012 Feb;24(2):484-92. PubMed: 21983012PAPER Gahete MD, Córdoba-Chacón J, Kineman RD, Luque RM, Castaño JP
Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease.
Peptides. 2011 Nov;32(11):2225-8. PubMed: 21983104PAPER Jagust WJ, Mormino EC
Lifespan brain activity, β-amyloid, and Alzheimer's disease.
Trends Cogn Sci. 2011 Nov;15(11):520-6. PubMed: 21983147PAPER Li J, Sheng W, Feng C, Zuo Z
Pyrrolidine dithiocarbamate attenuates brain Aβ increase and improves long-term neurological outcome in rats after transient focal brain ischemia.
Neurobiol Dis. 2012 Jan;45(1):564-72. PubMed: 21983158PAPER Giulietti G, Bozzali M, Figura V, Spanò B, Perri R, Marra C, Lacidogna G, Giubilei F, Caltagirone C, Cercignani M
Quantitative magnetization transfer provides information complementary to grey matter atrophy in Alzheimer's disease brains.
Neuroimage. 2012 Jan 16;59(2):1114-22. PubMed: 21983184PAPER Reiman EM,
Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments.
Neurobiol Aging. 2011 Dec;32 Suppl 1:S44-7. PubMed: 21983241PAPER Aisen PS
Clinical trial methodologies for disease-modifying therapeutic approaches.
Neurobiol Aging. 2011 Dec;32 Suppl 1:S64-6. PubMed: 21983242PAPER Spector A, Orrell M, Schepers A, Shanahan N
A systematic review of 'knowledge of dementia' outcome measures.
Ageing Res Rev. 2012 Jan;11(1):67-77. PubMed: 21983429PAPER Bruno D, Pomara N, Nierenberg JJ, Ritchie JC, Lutz MW, Zetterberg H, Blennow K
Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.
Exp Gerontol. 2011 Oct 1; PubMed: 21983493PAPER Jatczak B, Leszek J, Siemieniec I, Sochocka M, Wiśniewska A, Tarkowski R, Bębenek M, Błach-Olszewska Z
Age- and disease-related innate immunity of human leukocytes ex vivo.
Exp Gerontol. 2012 Jan;47(1):8-13. PubMed: 21983494PAPER McPherson PA, McEneny J
The biochemistry of ketogenesis and its role in weight management, neurological disease and oxidative stress.
J Physiol Biochem. 2011 Oct 8; PubMed: 21983804PAPER Liu X, Li L, Liu F, Deng S, Zhu R, Li Q, He Z
ApoE gene polymorphism and vascular dementia in Chinese population: a meta-analysis.
J Neural Transm. 2011 Oct 9; PubMed: 21984189Current Filters
No filters selected